OvaScience, a fertility company, has raised $4 in venture capital, according to a new filing by the company with the Securities and Exchange Commission. 116 separate investors participated in the offering. Oppenheimer, Livingston, and Leerink Swann all acted as brokers in the deal.

OvaScience is a fertility company focused on the discovery, development and commercialization of new treatments for infertility. OvaScience is working to improve the treatment of female infertility based on patented technology exclusively licensed from Massachusetts General Hospital. The company's team of scientists, physicians and advisers includes recognized leaders in the field of reproductive medicine.